Ghost Tree Capital, LLC
Filing Date
Global Rank
#3,254
/ 7,303
▼ 306
Top Industry
Biotechnology
91.0%
3Y Alpha vs SPY
-15.2%
Period ended 1 year ago
Filed Nov 14, 2024 · 1y
19 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+18.7%
SPY
+76.5%
Annualised alpha
-15.0%
Max drawdown
−46.0%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
48 positions · as of Sep 30, 2024 · Δ vs Jun 30, 2024Top Position
5.6%
−1.6 pts
Top 5
23.0%
−3.7 pts
Top 10
40.1%
−4.9 pts
HHI
291
Diversified−26
Portfolio Trend
19 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2024| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $267,890,704 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
15 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| TSHA | Taysha Gene Therapies, Inc. | +900,000 | 2,150,000 | $4,321,500 | |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | +205,000 | 380,000 | $7,839,400 | |
| NUVB | Nuvation Bio Inc. | +200,000 | 1,350,000 | $3,091,500 | |
| TNYA | Tenaya Therapeutics, Inc. | +150,000 | 1,500,000 | $2,895,000 | |
| JANX | Janux Therapeutics, Inc. | +140,000 | 190,000 | $8,631,700 | |
| ANNX | Annexon, Inc. | +125,500 | 650,000 | $3,848,000 | |
| TARS | Tarsus Pharmaceuticals, Inc. | +115,000 | 350,000 | $11,511,500 | |
| SNDX | Syndax Pharmaceuticals Inc | +100,000 | 450,000 | $8,662,500 | |
| RGNX | REGENXBIO Inc. | +95,000 | 265,000 | $2,779,850 | |
| ARVN | Arvinas, Inc. | +70,000 | 145,000 | $3,571,350 | |
| SRPT | Sarepta Therapeutics, Inc. | +65,000 | 120,000 | $14,986,800 | |
| RZLT | Rezolute, Inc. | +53,494 | 1,474,995 | $7,153,725 | |
| VKTX | Viking Therapeutics, Inc. | +45,000 | 140,000 | $8,863,400 | |
| BBIO | BridgeBio Pharma, Inc. | +35,000 | 175,000 | $4,455,500 | |
| KRRO | Korro Bio, Inc. | +10,000 | 110,000 | $3,676,200 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
22 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| VRDN | Viridian Therapeutics, Inc.DE | −512,708 | 75,000 | $1,706,250 | |
| SVRA | Savara Inc | −325,876 | 725,000 | $3,074,000 | |
| ENGN | enGene Therapeutics Inc. | −259,433 | 160,898 | $1,061,926 | |
| PHAT | Phathom Pharmaceuticals, Inc. | −225,000 | 375,000 | $6,780,000 | |
| ROIV | Roivant Sciences Ltd. | −200,000 | 800,000 | $9,232,000 | |
| SYRE | Spyre Therapeutics, Inc. | −190,237 | 60,000 | $1,764,600 | |
| TGTX | Tg Therapeutics, Inc. | −190,000 | 310,000 | $7,250,900 | |
| CATX | Perspective Therapeutics, Inc. | −175,000 | 750,000 | $10,012,500 | |
| MLTX | MoonLake Immunotherapeutics | −171,589 | 128,411 | $6,474,482 | |
| SLNO | Soleno Therapeutics Inc | −150,000 | 150,000 | $7,573,500 | |
| INSM | INSMED Inc | −140,000 | 125,000 | $9,125,000 | |
| CRNX | Crinetics Pharmaceuticals, Inc. | −90,000 | 150,000 | $7,665,000 | |
| PCVX | Vaxcyte, Inc. | −70,000 | 80,000 | $9,141,600 | |
| APLS | Apellis Pharmaceuticals, Inc. | −70,000 | 65,000 | $1,874,600 | |
| IMVT | Immunovant, Inc. | −45,000 | 215,000 | $6,129,650 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | −38,546 | 78,842 | $4,130,532 | |
| ASND | Ascendis Pharma A/S | −34,221 | 52,500 | $7,838,775 | |
| NGNE | Neurogene Inc. | −20,000 | 50,000 | $2,098,000 | |
| OLMA | Olema Pharmaceuticals, Inc. | −15,000 | 535,000 | $6,387,900 | |
| AXSM | Axsome Therapeutics, Inc. | −15,000 | 135,000 | $12,132,450 | |
| PRQR | ProQR Therapeutics N.V. | −12,300 | 887,700 | $1,615,614 | |
| CGON | CG Oncology, Inc. | −10,000 | 250,000 | $9,432,500 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
9 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| NVO | Novo Nordisk A S | 110,000 | $13,097,700 | |
| EWTX | Edgewise Therapeutics, Inc. | 195,000 | $5,204,550 | |
| DYN | Dyne Therapeutics, Inc. | 100,000 | $3,592,000 | |
| CRVS | Corvus Pharmaceuticals, Inc. | 500,000 | $2,640,000 | |
| ABSI | Absci Corp | 550,000 | $2,101,000 | |
| CAPR | Capricor Therapeutics, Inc. | 125,000 | $1,901,250 | |
| SMMT | Summit Therapeutics Inc. | 85,000 | $1,861,500 | |
| LRMR | Larimar Therapeutics, Inc. | 200,000 | $1,310,000 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | 325,000 | $1,053,000 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
15 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals, Inc. | 90,900 | $22,088,700 | |
| BHVN | Biohaven Ltd. | 490,000 | $17,007,900 | |
| ACAD | Acadia Pharmaceuticals Inc | 225,000 | $3,656,250 | |
| CABA | Cabaletta Bio, Inc. | 370,899 | $2,774,324 | |
| CYTK | Cytokinetics Inc | 33,200 | $1,798,776 | |
| KRYS | Krystal Biotech, Inc. | 8,500 | $1,560,940 | |
| WVE | Wave Life Sciences Ltd. | 200,000 | $998,000 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 35,000 | $909,650 | |
| SGMT | Sagimet Biosciences Inc. | 225,000 | $769,500 | |
| MGNX | Macrogenics Inc | 150,000 | $637,500 | |
| PMVP | PMV Pharmaceuticals, Inc. | 375,000 | $607,500 | |
| PTCT | Ptc Therapeutics, Inc. | 19,000 | $581,020 | |
| NTLA | Intellia Therapeutics, Inc. | 25,000 | $559,500 | |
| ANTX | AN2 Therapeutics, Inc. | 219,331 | $471,561 | |
| CTMX | CytomX Therapeutics, Inc. | 300,000 | $366,000 | |
| No positions match the current search. | ||||
48 positions ·
$267,890,704 total
· as of Sep 30, 2024
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SRPT |
Sarepta Therapeutics, Inc.
Healthcare
|
Added | 120,000 | $14,986,800 | 5.59% | |
| NVO |
Novo Nordisk A S
Healthcare
|
NEW | 110,000 | $13,097,700 | 4.89% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Reduced | 135,000 | $12,132,450 | 4.53% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Added | 350,000 | $11,511,500 | 4.30% | |
| CATX |
Perspective Therapeutics, Inc.
Healthcare
|
Reduced | 750,000 | $10,012,500 | 3.74% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
Reduced | 250,000 | $9,432,500 | 3.52% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Reduced | 800,000 | $9,232,000 | 3.45% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Reduced | 80,000 | $9,141,600 | 3.41% | |
| INSM |
INSMED Inc
Healthcare
|
Reduced | 125,000 | $9,125,000 | 3.41% | |
| VKTX |
Viking Therapeutics, Inc.
Healthcare
|
Added | 140,000 | $8,863,400 | 3.31% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Added | 450,000 | $8,662,500 | 3.23% | |
| JANX |
Janux Therapeutics, Inc.
Healthcare
|
Added | 190,000 | $8,631,700 | 3.22% | |
| CRBP |
Corbus Pharmaceuticals Holdings, Inc.
Healthcare
|
Added | 380,000 | $7,839,400 | 2.93% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Reduced | 52,500 | $7,838,775 | 2.93% | |
| CRNX |
Crinetics Pharmaceuticals, Inc.
Healthcare
|
Reduced | 150,000 | $7,665,000 | 2.86% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
Reduced | 150,000 | $7,573,500 | 2.83% | |
| TGTX |
Tg Therapeutics, Inc.
Healthcare
|
Reduced | 310,000 | $7,250,900 | 2.71% | |
| RZLT |
Rezolute, Inc.
Healthcare
|
Added | 1,474,995 | $7,153,725 | 2.67% | |
| PHAT |
Phathom Pharmaceuticals, Inc.
Healthcare
|
Reduced | 375,000 | $6,780,000 | 2.53% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
Reduced | 128,411 | $6,474,482 | 2.42% | |
| OLMA |
Olema Pharmaceuticals, Inc.
Healthcare
|
Reduced | 535,000 | $6,387,900 | 2.38% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Reduced | 215,000 | $6,129,650 | 2.29% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
NEW | 195,000 | $5,204,550 | 1.94% | |
| REPL |
Replimune Group, Inc.
Healthcare
|
Held | 450,000 | $4,932,000 | 1.84% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Added | 175,000 | $4,455,500 | 1.66% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
Added | 2,150,000 | $4,321,500 | 1.61% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Reduced | 78,842 | $4,130,532 | 1.54% | |
| ANNX |
Annexon, Inc.
Healthcare
|
Added | 650,000 | $3,848,000 | 1.44% | |
| KRRO |
Korro Bio, Inc.
Healthcare
|
Added | 110,000 | $3,676,200 | 1.37% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
NEW | 100,000 | $3,592,000 | 1.34% | |
| ARVN |
Arvinas, Inc.
Healthcare
|
Added | 145,000 | $3,571,350 | 1.33% | |
| NUVB |
Nuvation Bio Inc.
Healthcare
|
Added | 1,350,000 | $3,091,500 | 1.15% | |
| SVRA |
Savara Inc
Healthcare
|
Reduced | 725,000 | $3,074,000 | 1.15% | |
| TNYA |
Tenaya Therapeutics, Inc.
Healthcare
|
Added | 1,500,000 | $2,895,000 | 1.08% | |
| RGNX |
REGENXBIO Inc.
Healthcare
|
Added | 265,000 | $2,779,850 | 1.04% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
Healthcare
|
NEW | 500,000 | $2,640,000 | 0.99% | |
| ABSI |
Absci Corp
Healthcare
|
NEW | 550,000 | $2,101,000 | 0.78% | |
| NGNE |
Neurogene Inc.
Healthcare
|
Reduced | 50,000 | $2,098,000 | 0.78% | |
| CAPR |
Capricor Therapeutics, Inc.
Healthcare
|
NEW | 125,000 | $1,901,250 | 0.71% | |
| APLS |
Apellis Pharmaceuticals, Inc.
Healthcare
|
Reduced | 65,000 | $1,874,600 | 0.70% | |
| SMMT |
Summit Therapeutics Inc.
Healthcare
|
NEW | 85,000 | $1,861,500 | 0.69% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Reduced | 60,000 | $1,764,600 | 0.66% | |
| VRDN |
Viridian Therapeutics, Inc.DE
Healthcare
|
Reduced | 75,000 | $1,706,250 | 0.64% | |
| PRQR |
ProQR Therapeutics N.V.
Healthcare
|
Reduced | 887,700 | $1,615,614 | 0.60% | |
| ATYR |
aTYR PHARMA INC
Healthcare
|
Held | 800,000 | $1,408,000 | 0.53% | |
| LRMR |
Larimar Therapeutics, Inc.
Healthcare
|
NEW | 200,000 | $1,310,000 | 0.49% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
Reduced | 160,898 | $1,061,926 | 0.40% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
NEW | 325,000 | $1,053,000 | 0.39% |